Serum Ceruloplasmin in Pre-eclampsia: A Case-Control Study in a Tertiary Health Centre in Southwest Nigeria.

Authors

Joy Onyinyechi Chionuma, Olusegun Cosmos Adebara, Nosimot Omolola Davies, Oladimeji Abiodun Makinde, Kabiru Afolarin Rabiu

Published in

The Nigerian postgraduate medical journal. Volume 33. Issue 5. Pages 665-671. Sep 01, 2026. Epub Aug 17, 2026.

Abstract

Pre-eclampsia is a pregnancy disorder linked with increased maternal and perinatal complications. An imbalance between free radical-induced lipid peroxidation and the antioxidant system may contribute to its pathogenesis.
This study aimed to compare serum ceruloplasmin levels in women with pre-eclampsia and their normotensive counterparts and to assess its predictive value for disease severity.
A prospective case-control study was conducted involving 100 pregnant women diagnosed with pre-eclampsia, matched for age and parity against 100 healthy controls. Patients with pre-eclampsia were classified into mild (55) and severe (45) pre-eclampsia groups. Data on demographics, obstetric characteristics and outcomes were collected. Ceruloplasmin protein concentration was measured using a competitive enzyme-linked immunosorbent assay kit. Data analysis was performed using Stata Version 17. The reference range of serum ceruloplasmin for determining the risk of pre-eclampsia was from the 2.5 th to the 97.5 th percentile of the controls. The statistical significance level was set at P < 0.05.
The median interquartile range (IQR) serum ceruloplasmin levels were 21 mg/dL (IQR 17.5-23.8) in normotensive women, 35.5 mg/dl (IQR, 33.8-38.3) in mild pre-eclampsia, and 46.5 mg/dL (IQR, 42.5-49) in severe pre-eclampsia, with significant differences ( P = 0.001). The cut-off point for serum ceruloplasmin using Youden's index was 29 mg/dL. Ceruloplasmin exhibited 90.8% sensitivity, 95.6% specificity and positive and negative predictive values and accuracy of 96.1%, 89.6% and 92.3%, respectively, in pre-eclampsia.
Serum ceruloplasmin was elevated in pre-eclampsia, and the levels correlate with the severity of pre-eclampsia. The sensitivity and specificity observed in this study suggest that ceruloplasmin may be a potential marker for discriminating between normotensive pregnant women and those with pre-eclampsia. Elevated levels may be an indicator of severe disease.

PMID:
42616982
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.